Literature DB >> 8510699

Thromboxane synthase and organ preference for metastases.

A A Nanji.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1993        PMID： 8510699     DOI： 10.1056/NEJM199307083290218

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  4 in total

1.  Inhibition of thromboxane synthase activity improves glioblastoma response to alkylation chemotherapy.

Authors:  Nils Ole Schmidt; Mateo Ziu; Theresa Cargioli; Manfred Westphal; Alf Giese; Peter M Black; Rona S Carroll
Journal:  Transl Oncol       Date:  2010-02       Impact factor: 4.243

2.  Defeating cancer with antidepressants.

Authors:  J Lieb
Journal:  Ecancermedicalscience       Date:  2008-08-21

3.  Inhibiting breast cancer by targeting the thromboxane A2 pathway.

Authors:  Haitao Li; Mee-Hyun Lee; Kangdong Liu; Ting Wang; Mengqiu Song; Yaping Han; Ke Yao; Hua Xie; Feng Zhu; Michael Grossmann; Margot P Cleary; Wei Chen; Ann M Bode; Zigang Dong
Journal:  NPJ Precis Oncol       Date:  2017-04-03

Review 4.  The Role and Regulation of Thromboxane A2 Signaling in Cancer-Trojan Horses and Misdirection.

Authors:  Anthony W Ashton; Yunjia Zhang; Rosanna Cazzolli; Kenneth V Honn
Journal:  Molecules       Date:  2022-09-22       Impact factor: 4.927
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.